Bruce Stillman

In REDC love fest, CSHL kicks off $75M makeover

By GREGORY ZELLER // There was another major advance for biochemistry Thursday at Cold Spring Harbor Laboratory, but this one didn’t involve gas chromatographs or infrared spectrometers or a single test tube. Just a shovel. With Gov. Andrew Cuomo and a host of regional and state representatives on hand, the world-class scientific research facility officially broke ground on the renovation of its Demerec Laboratory, one of four CSHL laboratories being remade with a big assist…


Donald Trump, Long Island and the war on science

By GREGORY ZELLER // There’s worry, if not panic, among the scientists at the heart of the Long Island innovation economy. Certainly, none are surprised that President Donald Trump, in his first proposed budget, took square aim at the federal funding that is the lifeblood of the nation’s scientific research programs. This is, after all, a president who calls climate change a hoax, champions coal and selected a former ExxonMobil CEO as his secretary of…


Northwell/CSHL cancer center draws an ace

An internationally renowned cancer expert will help lead Northwell Health and Cold Spring Harbor Laboratory’s joint cancer-research initiative. Oncologist Robert Maki, known primarily as a leading sarcoma physician and researcher, will direct the Center for New Cancer Therapies at the Northwell Health Cancer Institute. The institute is a strategic affiliation between the New Hyde Park-based health system and CSHL, established in 2015 to accelerate cancer research and the development of new therapies. As director, Maki…


Stillman steps down as CSHL Cancer Center chief

By GREGORY ZELLER // After a quarter-century of heralded stewardship, Bruce Stillman is stepping away from his role as head of the Cold Spring Harbor Laboratory Cancer Center. Stillman was appointed Cancer Center director in 1992, succeeded CSHL icon James Watson as laboratory director in 1994 and was appointed president in 2003. He’ll still call the shots as CSHL’s president and CEO and will also continue his personal research into DNA replication and genome inheritance. But his…


Patent Board rejects challenge to CSHL research

By GREGORY ZELLER // A big win before the U.S. Patent Trial and Appeal Board will keep a versatile biomedical-research and drug-discovery tool in Cold Spring Harbor Laboratory’s possession. The ruling means short hairpin RNA – invented by CSHL professor Gregory Hannon and his team – will remain the exclusive domain of Hairpin Technologies, a licensing agent spun out of the laboratory in 2015 to negotiate and execute shRNA licensing agreements with manufacturers and distributors….


The Debrief: Linda Amper is breathing life into the life sciences

The Long Island Association has hired former OSI Pharmaceuticals exec Linda Amper to help launch Long Island Bio, a business-development platform to be co-chaired by Cold Spring Harbor Laboratory chief Bruce Stillman and Canon USA Executive VP Seymour Liebman. The biotech, pharma and life sciences platform is right in Amper’s wheelhouse: The PhD (healthcare administration, Columbia Southern), who also holds a master’s in public administration from LIU Post, spent years in senior-executive positions with OSI…


Monday Debrief: Bruce Stillman. The Man.

There’s barely enough room on the Internet to list Bruce Stillman’s educational credentials and professional accomplishments – his list of awards and honors runs the length of your typical DNA strand. Suffice it to say: In the annals of scientific research, particularly cellular-structure research, the Australian-born biochemist is The Man. Under his watch, CSHL has been ranked the nation’s No. 1 institution for molecular biology and genetics research; it’s also grown into an essential role…


CSHL's Bruce Stillman

CSHL plans new center to push research to market

BY JOHN L. KOMINICKI // Cold Spring Harbor Laboratory plans a $75 million therapeutic research center that would help speed to market treatments for cancer, autism and other diseases without waiting for the pharmaceutical industry to “catch up,” lab director Bruce Stillman said Tuesday. The center, which would rely on a $25 million grant from New York State and $50 million from the National Institutes of Health, would help cure a persistent problem with commercializing…


DNA discoverer James Watson

Watson makes $1M CSHL gift

A million-dollar donation to Cold Spring Harbor Laboratory? Doctor Watson, we presume. And that presumption, of course, is correct: CSHL Chancellor Emeritus James Watson and his wife, Liz, have done it again, donating $1 million to support biomedical research and education at the laboratory, where Watson served as director for decades. That makes a tidy $5 million donated to CSHL, to date, by Watson, a Chicago-born molecular biologist, zoologist and geneticist who led the National…


CSHL's Bruce Stillman

North Shore-LIJ, CSHL in cancer partnership

Cold Spring Harbor Laboratory and North Shore-LIJ announced a joint cancer research and treatment effort that is designed to speed the region’s most-promising research to patients. The affiliation will better connect researchers at CSHL and North Shore’s Feinstein Institute for Medical Research and provide patients for clinical trials of the latest treatments, linking scieentists with more than 200 oncologists at North Shore-LIJ’s Cancer Institute. Cold Spring Harbor CEO Bruce Stillman called the paertnership a “transformative…